NX Development Corp
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) (NCT05804370) | NX Development Corp | 2024-05-30 |
| Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma (NCT04305470) | NX Development Corp | 2020-10-28 |
Track NX Development Corp automatically
Every clearance here is in the API, with alerts when new ones post.